Moderna’s mRNA Flu Vaccine Wins FDA Advisory Committee Backing

Moderna Inc.’s influenza vaccine made with mRNA technology was recommended for approval by outside advisers to the US Food and Drug Administration. According to Bloomberg, the backing is a positive development for a product that has been contentious at the agency.